Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Two, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of the Travelers' Diarrhea Vaccine System in Travelers to Asia

NCT01040325 is registered in ClinicalTrials.gov with Intercell USA, Inc. as lead sponsor.

NCT NCT01040325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01040325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Two, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of the Travelers' Diarrhea Vaccine System in Travelers to Asia
Lead sponsor
Intercell USA, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2009
Completion date
December 31, 2010
Enrollment
723 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

traveler's diarrhea